case of congenital giant right coronary artery which had a fistulous connection to the coronary sinus (CS) and left persistent superior vena cava treated with medical therapy.
Case
A 63-year-old female presented with dyspnea on exertion, orthopnea, and facial edema. She had underlying type 2 diabetes, Parkinsonism, as well as osteoporosis.
At the time of admission, the patient's blood pressure was 100/60 mm Hg, pulse rate was 67/min, and peripheral oxygen saturation was 97%. Physical examination showed mild facial edema without other peripheral limb edemas. The neck vein was slightly engorged. On auscultation, no prominent cardiac murmur was heard.
All laboratory values were unremarkable. Chest roentgenography showed an increased cardiothoracic ratio of 0.72 with mild pulmonary congestion. Electrocardiogram showed normal sinus rhythm with left axis deviation. Initial echocardiogram revealed marked dilatation of the right coronary artery (15 mm in diameter) from the initial segment, running along the posterior wall of the left ventricle and terminating around the CS with shunt flow (Fig. 1) . The left ventricle was dilated with normal contractility and wall thickness. Computed tomography (CT) angiogram (Fig. 2) , following invasive coronary angiogram (Fig. 3B ), was performed due to complex anatomy. www.e-kcj.org
CT revealed a right coronary artery to CS fistula with persistent left superior vena cava (PLSVC), low lying left innominate vein, and right atrial enlargement possibly due to a left to right shunt. Cardiac catheterization was performed to determine the amount of shunt flow (Fig. 3A) . Cardiac catheterization revealed significant oxygen step-up in the right atrium (RA) { oxygen saturations were as follows: right jugular vein, 51.4%; left subclavian vein, 70.3%; superior vena cava 64.2%; PLSVC (upper) 82.8%; PLSVC (lower) 86.7%; CS ostium 75.7%, high RA 66.4%; mid RA 74.7%; low RA 73.3%; right ventricle 75.8%; pulmonary artery 75.8%, inferior vena cava 61.5% } . The estimated ratio of pulmonary blood flow to systemic blood flow (Qp/Qs) was approximately 1.53.
Based on a multidisciplinary team approach taking into account the patient age and activity level as well as the amount of shunt flow, we concluded to treat her with combination therapy using angiotensin converting enzyme inhibitor and diuretics. After approximately 10 months from the date of discharge, the patient has been doing well without symptom.
Discussion
Coronary arteriovenous fistula is rare cardiac anomaly with a known incidence of 0.3-0.8%. 9) Low-pressure structures such as pulmonary artery, superior vena cava, and CS are frequent termination sites of fistulous connections. 9) Possible complications include heart failure, angina, endocarditis, arrhythmias, stroke, myocardial ischemia or myocardial infarction due to coronary steal. 10) Thus the antiplatelet therapy, especially for patients with distal coronary artery fistulas, abnormally dilated coronary arteries, and prophylactic precautions of subacute bacterial endocarditis, is recommended.
8)
We were able to find eight cases of congenial giant right coronary artery to CS reported in the literature (Table 1) .
3-6)11-14) Five out of 8 cases were repaired with surgery. Some authors insist, in order to prevent potential complications, that early surgical intervention is the best treatment. nital CAVF with surgical therapy and found that postoperative complications increase in patients over 20 years of age. In our case, the patient was treated with loop diuretics and spironolactone for several days after admission after which her facial edema and dyspnea gradually improved. Initially surgical correction or catheter-based closure of fistula was considered, however for symptom improvement, we came across an opportunity to treat with medical therapy. This case suggests that heart failure symptom with Qp/Qs over 1.5 may not be a clear-cut indication for surgery.
14)
In conclusion, we report a rare case of CAVF from giant right coronary artery presented with dyspnea and facial edema. To determine the appropriate therapeutic strategy for a rare case such as this one presenting with congenital anomalies, we need to take into account the overall conditions and well-being of the patient. 
